Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Teva pharmaceutical industries ltd crawled time : 21:00 save search
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)
Published: 2024-04-16 (Crawled : 21:00) - globenewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.04%
H: 0.28%
C: -0.16%
stelara fda biosimilar approval teva
Alvotech Announces Webcast of Full Year 2023 Financial Results on March 21, 2024, at 8:00 am ET
Published: 2024-03-05 (Crawled : 21:00) - globenewswire.com
ALVO | $12.9 0.78% 0.78% 90K
|
n/a
|
| O: -0.99%
H: 0.75%
C: -0.13%
KMDA | $5.075 -0.1% -0.1% 6.5K
|
Health Technology
|
| O: -6.12%
H: 1.67%
C: 1.17%
year financial results
Alvotech Appoints Interim Chief Quality Officer
Published: 2024-02-29 (Crawled : 21:00) - globenewswire.com
ALVO | $12.9 0.78% 0.78% 90K
|
n/a
|
| O: -0.58%
H: 3.04%
C: 3.01%
KMDA | $5.075 -0.1% -0.1% 6.5K
|
Health Technology
|
| O: -1.27%
H: 2.97%
C: 2.41%
Alvotech Reports Financial Results for First Nine Months of 2023 and Provides Business Update
Published: 2023-11-28 (Crawled : 21:00) - globenewswire.com
ALVO | $12.9 0.78% 0.78% 90K
|
n/a
|
| O: 1.02%
H: 0.0%
C: -5.05%
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.18%
H: 0.12%
C: -0.16%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
ABBV | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.73%
H: 0.78%
C: 0.35%
KMDA | $5.075 -0.1% -0.1% 6.5K
|
Health Technology
|
| O: 0.73%
H: 0.0%
C: -1.04%
business update financial results
Alvotech Reports Financial Results for First Nine Months of 2023 and Provides a Business Update
Published: 2023-11-28 (Crawled : 21:00) - globenewswire.com
ALVO | $12.9 0.78% 0.78% 90K
|
n/a
|
| O: 1.02%
H: 0.0%
C: -5.05%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
ABBV | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.73%
H: 0.78%
C: 0.35%
KMDA | $5.075 -0.1% -0.1% 6.5K
|
Health Technology
|
| O: 0.73%
H: 0.0%
C: -1.04%
business update financial results
Contraceptives Global Market Exhibit Growth at a CAGR of ~5% by 2027 | DelveInsight
Published: 2023-08-23 (Crawled : 21:00) - prnewswire.com
RBGPF | $52.0 6.46% 34K
|
Consumer Non-Durables
|
| O: -1.89%
H: 1.87%
C: 1.22%
RBGLY | $10.29 -2.05% 1.4M
|
Manufacturing
|
| O: -0.56%
H: 0.81%
C: -0.07%
VTRS | $11.11 0.09% 0.09% 3.5M
|
Health Technology
|
| O: -0.73%
H: 2.01%
C: 0.27%
ABBV | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.06%
H: 0.0%
C: 0.0%
VERU | $1.42 22.41% 18.31% 7M
|
Health Technology
|
| O: 1.92%
H: 0.0%
C: -2.83%
TXMD | News | $1.98 4.76% 4.55% 5.7K
|
Health Technology
|
| O: -2.8%
H: 0.0%
C: 0.0%
global contraceptives growth market
Teva to Present New Data from CONNECT2 Study on its Digihaler® System at the American Academy of Allergy, Asthma and Immunology (AAAAI) 2023 Annual Meeting
Published: 2023-02-24 (Crawled : 21:00) - biospace.com/
TEVA | $12.78 -3.03% -0.24% 9M
|
Health Technology
|
| O: -1.2%
H: 1.11%
C: 0.2%
digihaler system immunology meeting teva study
The Worldwide Contraceptives Industry is Expected to Reach $39 Billion by 2027
Published: 2023-01-31 (Crawled : 21:00) - prnewswire.com
RBGPF | $52.0 6.46% 34K
|
Consumer Non-Durables
|
| O: -1.29%
H: 1.65%
C: 1.65%
RBGLY | $10.29 -2.05% 1.4M
|
Manufacturing
|
| O: -1.25%
H: 0.77%
C: 0.56%
VERU | $1.42 22.41% 18.31% 7M
|
Health Technology
|
| O: -0.35%
H: 3.14%
C: 2.79%
expected contraceptives
Contraceptives Global Market Report 2022: by Product, Age Group, Distribution Channel and Region
Published: 2023-01-26 (Crawled : 21:00) - prnewswire.com
RBGPF | $52.0 6.46% 34K
|
Consumer Non-Durables
|
| O: -0.49%
H: 1.68%
C: 0.6%
RBGLY | $10.29 -2.05% 1.4M
|
Manufacturing
|
| O: -1.4%
H: 0.14%
C: -0.5%
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: -0.07%
H: 0.27%
C: -0.97%
global report distribution contraceptives market
Insights on the Alzheimer's Drugs Global Market to 2027 - Hospital Sector will Capture more Revenue in Upcoming Years
Published: 2023-01-25 (Crawled : 21:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -0.96%
H: 0.0%
C: 0.0%
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: -1.93%
H: 0.23%
C: 0.11%
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -1.97%
H: 0.11%
C: -1.25%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 0.4%
H: 0.28%
C: 0.08%
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.36%
H: 0.34%
C: -0.85%
ABT | News | $105.27 -0.6% -0.15% 7.3M
|
Health Technology
|
| O: 0.23%
H: 0.33%
C: -0.16%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
global alzheimer's market
Active Pharmaceutical Ingredient Global Market Report 2023: Featuring Teva Pharmaceutical, Bristol-Myers Squibb, Merck
Published: 2023-01-04 (Crawled : 21:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -1.77%
H: 0.75%
C: 0.75%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -1.28%
H: 0.35%
C: -0.29%
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -0.59%
H: 0.15%
C: -0.56%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: -1.21%
H: 0.89%
C: 0.25%
ABBV | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.37%
H: 0.86%
C: 0.25%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -3.07%
H: 0.0%
C: 0.0%
global active report teva market
Hagens Berman Sobol Shapiro LLP, Hilliard & Shadowen LLP, and Durie Tangri LLP Announce a Class Action Involving Antiretroviral Drugs
Published: 2022-12-28 (Crawled : 21:00) - prnewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.5%
H: 0.42%
C: 0.01%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: 0.43%
H: 0.47%
C: -0.28%
GILD | $66.16 -1.15% -1.16% 6.4M
|
Health Technology
|
| O: 0.4%
H: 0.78%
C: 0.41%
Acute Ischemic Stroke Therapeutics Market: Growth Opportunities led by Athersys Inc. and Bayer AG - Technavio
Published: 2022-11-28 (Crawled : 21:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 0.36%
H: 0.16%
C: 0.16%
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: -1.93%
H: 0.0%
C: 0.0%
MDT | News | $79.19 0.14% 0.0% 6.1M
|
Health Technology
|
| O: 0.35%
H: 0.99%
C: 0.1%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.18%
H: 0.14%
C: -0.52%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: -0.27%
H: 0.99%
C: 0.11%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: 0.21%
H: 0.16%
C: -0.41%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.27%
H: 0.0%
C: -0.49%
stroke therapeutics growth
Amlodipine Besylate Market size to grow by USD 217.26 Million; High blood pressure segment exhibits high growth - Technavio
Published: 2022-11-22 (Crawled : 21:00) - prnewswire.com
TEVJF | $12.37 -24.22% 380
|
Health Technology
| Email alert
Add to watchlist
blood growth market
Insights on the Narcolepsy Therapeutics Global Market to 2028 - Featuring Jazz Pharmaceuticals, Pfizer, Bioprojet and Takeda Pharmaceutical Among Others
Published: 2022-11-21 (Crawled : 21:00) - prnewswire.com
TAK | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: 0.71%
H: 0.85%
C: 0.42%
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: 0.33%
H: 1.88%
C: 1.53%
JAZZ | News | $109.3 2.05% 2.01% 560K
|
Health Technology
|
| O: 0.28%
H: 2.75%
C: 2.63%
global narcolepsy therapeutics market
Alvotech to Participate in Upcoming Jefferies London Healthcare Conference in November
Published: 2022-10-26 (Crawled : 21:00) - globenewswire.com
ALVO | $12.9 0.78% 0.78% 90K
|
n/a
|
| O: -1.63%
H: 4.15%
C: 0.5%
KMDA | $5.075 -0.1% -0.1% 6.5K
|
Health Technology
|
| O: -1.65%
H: 0.32%
C: -1.26%
conference
Global Central Nervous System Therapeutics Market to Grow at Healthy CAGR Due to Rising Disorder Prevalence & Technical Advancements
Published: 2022-09-19 (Crawled : 21:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -6.97%
H: 7.7%
C: -0.76%
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: -0.34%
H: 6.64%
C: -0.06%
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.96%
H: 0.0%
C: 0.0%
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.82%
H: 0.07%
C: -0.61%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.33%
H: 0.0%
C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -0.71%
H: 0.2%
C: -0.23%
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: -0.69%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -1.18%
H: 0.0%
C: 0.0%
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: -0.71%
H: 0.08%
C: -1.72%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: -1.16%
H: 0.56%
C: 0.14%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.98%
H: 0.65%
C: -0.35%
global system therapeutics market
Global Opioids Market to 2027 - Size, Share & Industry Trends Analysis Report
Published: 2022-06-24 (Crawled : 21:00) - prnewswire.com
ENDP | $0.2926 -9.6%
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
| Email alert
Add to watchlist
MNKKQ | $0.02
|
Manufacturing
| Email alert
Add to watchlist
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
| Email alert
Add to watchlist
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
| Email alert
Add to watchlist
AZNCF | $140.15 -4.19% 560
|
Health Technology
| Email alert
Add to watchlist
MNK | $0.3402 -0.06% 540K
|
n/a
| Email alert
Add to watchlist
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
| Email alert
Add to watchlist
TEVJF | $12.37 -24.22% 380
|
Health Technology
| Email alert
Add to watchlist
trends report market
FDA Approves Dupixent® (dupilumab) as First Biologic Medicine for Children Aged 6 Months to 5 Years with Moderate-to-severe Atopic Dermatitis
Published: 2022-06-07 (Crawled : 21:00) - prnewswire.com
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.36%
H: 0.0%
C: 0.0%
REGN | $893.66 -0.84% -0.84% 450K
|
Health Technology
|
| O: 2.14%
H: 0.78%
C: -1.66%
dupixent fda children dermatitis
Press Release: FDA approves Dupixent® (dupilumab) as first biologic medicine for children aged 6 months to 5 years with moderate-to-severe atopic dermatitis
Published: 2022-06-07 (Crawled : 21:00) - globenewswire.com
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.36%
H: 0.0%
C: 0.0%
REGN | $893.66 -0.84% -0.84% 450K
|
Health Technology
|
| O: 2.14%
H: 0.78%
C: -1.66%
dupixent fda children dermatitis
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.